Here's why I think a2 Milk Company Ltd (Australia) could still be a good investment

a2 Milk Company Ltd (Australia) (ASX:A2M) just updated the market with some good news.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a2 Milk Company Ltd (Australia) (ASX: A2M) has been one of the standout performers on the ASX over the last year with the share price up by 253%.

The company gave an update yesterday at its AGM stating how it was going so far this financial year. Sufficed to say, the update was impressive. For the four months to October 2017 the results were:

  • Revenue growth of 68.9%
  • Earnings before interest, tax, depreciation and amortisation (EBITDA) growth of 120.8%
  • Net profit after tax growth of 137.7%

However, investors may be short-sighted if they think that this year will be the end of the impressive growth.

A2 has well and truly established itself as a market leader of dairy products in Australia and New Zealand. Here are a few reasons why I think it could keep smashing the market:

Growing margins

A2's scale is growing all the time, which means economies of scale are playing a bigger role with more products being produced and sold.

In its AGM update it revealed that for the four months to October 2017 the EBITDA margin had grown from 22.9% to 29.9% compared to the prior corresponding period.

New products

The business is frequently coming out with new products.

One of its latest ideas is stage four infant formula which is made for children over the age of three. This product could also soon be sold out everywhere and give A2 another source of exciting income if the daigou get excited by it.

China

China is already a large and growing market for A2 with direct and indirect sales growing strongly.

However, I think a key driver of future growth will be that the Chinese government has abolished the one-baby policy and the growing number of babies will flow through to increased formula demand in a couple of years.

Foolish takeaway

A2 is definitely not cheap at $7.46 per share, however there is every chance that it will continue to outperform the market if it can keep growing at its current pace.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »